The FDA said in an alert issued to healthcare providers and the public that the outer carton is counterfeit, while the vial inside is labeled as a foreign version of Botox, which is not approved for sale in the United Sates.
"FDA cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards," the agency said. - Reuters
source: gmanetwork.com
